Altor BioScience and Shenzhen Beike Biotechnology Announce License Agreement for Immunotherapeutic ALT-803 in China
MIRAMAR, Fla. & SHENZHEN, China, Sep 10, 2014 (BUSINESS WIRE) — Altor BioScience Corporation (Altor), a U.S.-based developer of novel cancer immunotherapies, and Shenzhen Beike Biotechnology Co., Ltd. (Beike), a…
Ice Bucket Challenge Sweeps China
On a hot and sunny day in coastal Shenzhen, China, a small group of Beike Biotechnology’s international department was preparing to dump buckets of ice water on themselves. Why? More…
Taizhou City, Jiangsu Province, China August 8, 2014 / PRNewswire / – In recent years, with the rapid development of stem cell biology, immunology, molecular techniques, tissue engineering and other…
Biotech Company Receives Application Approval from Chinese Food and Drug Administration
SHENZHEN, China, July 10, 2014 /PRNewswire/ — Beike Biotechnology Co., Ltd. (Beike) has officially been accepted into the approval process for the Chinese Food and Drug Administration for the use…
Beike Biotech Celebrates 9 Years of Incorporation
On Friday July 18th Beike Biotech celebrated its 9th year as an incorporated company. In honor of this day all staff wore a red Beike shirt in order to show…
Chinese researchers find stem cells effective in treating Systemic Lupus Erythematosus
Chinese researchers have recently published new findings in Arthritis Research & Therapy, a top peer-reviewed journal in the field of systemic autoimmune rheumatic diseases, regarding the safety and effectiveness of umbilical cord (UC)…